Collegium Pharma (COLL) Tops Q1 EPS by 15c

Go back to Collegium Pharma (COLL) Tops Q1 EPS by 15c

Collegium Reports Record Quarterly Revenue of $87.7 Million

May 6, 2021 4:01 PM EDT

Net Income of $15.7 Million and Adjusted EBITDA of $45.3 Million in the First Quarter of 2021

Nucynta® Franchise and Adjusted EBITDA 2021 Guidance Range Raised

Colleen Tupper Appointed as Next CFO; Paul Brannelly will be Leaving the Company to Pursue Other Opportunities

Conference Call Scheduled for Today at 4:30 p.m. ET

STOUGHTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) --... More